Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaques B Bluett

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Applied Clinical Medical Physics|July 10, 2013
Analysis of esophageal-sparing treatment plans for patients with high-grade esophagitisJoshua Niedzielski, Jaques B Bluett, Ryan T Williamson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prescribing radiation dose to lung cancer patients based on personalized toxicity estimatesYevgeniy Vinogradskiy, Susan L Tucker, Jaques B Bluett, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2008
Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plansSamir V Sejpal, Richard A Amos, Jaques B Bluett, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2011
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancerJoe Y Chang, Ritsuko Komaki, Hong Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomasNicholas S Boehling, David R Grosshans, Jaques B Bluett, et al.
Radiation Oncology (London, England)|May 5, 2016
Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLCTawfik Giaddui, Wenzhou Chen, Jialu Yu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Applied Clinical Medical Physics|July 10, 2013
Analysis of esophageal-sparing treatment plans for patients with high-grade esophagitisJoshua Niedzielski, Jaques B Bluett, Ryan T Williamson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prescribing radiation dose to lung cancer patients based on personalized toxicity estimatesYevgeniy Vinogradskiy, Susan L Tucker, Jaques B Bluett, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2008
Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plansSamir V Sejpal, Richard A Amos, Jaques B Bluett, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2011
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancerJoe Y Chang, Ritsuko Komaki, Hong Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomasNicholas S Boehling, David R Grosshans, Jaques B Bluett, et al.
Radiation Oncology (London, England)|May 5, 2016
Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLCTawfik Giaddui, Wenzhou Chen, Jialu Yu, et al.
Pageof 1